Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
37
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFICER | 6 | $0 | $0 | 2024-02-12 |
| White Lauren | SVP, CFO AND PFO | 6 | $0 | $0 | 2024-02-12 |
| Lentini Renee | VP & PRIN ACCTG OFFICER | 66 | $0 | $6.23M | 2024-02-12 |
| Coen Stacy Ann | SVP & Chief Business Officer | 52 | $0 | $4.86M | 2024-02-12 |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | 5 | $0 | $0 | 2024-02-12 |
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | 6 | $0 | $0 | 2024-02-12 |
| McCain Tracey L | Director | 15 | $0 | $0 | 2024-02-12 |
| Thackray Helen M. | Director | 16 | $0 | $0 | 2024-02-12 |
| Enyedy Mark J | Chief Executive Officer | 50 | $45.8K | $53.03M | 2024-02-12 |
| Arbuckle Stuart A | Director | 29 | $0 | $0 | 2024-02-12 |
| Goldberg Mark Alan | Director | 76 | $242.6K | $0 | 2024-02-12 |
| Wingrove Theresa | VP of Regulatory Affairs | 86 | $0 | $23.30M | 2024-02-12 |
| Peterson Kristine | Director | 42 | $0 | $578.0K | 2024-02-12 |
| Wallace Richard John | Director | 39 | $0 | $0 | 2024-02-12 |
| MITCHELL DEAN J | Director | 69 | $125.1K | $0 | 2024-02-12 |
| MCCLUSKI STEPHEN C | Director | 39 | $0 | $0 | 2024-02-12 |
| Berkenblit Anna | VP & Chief Medical Officer | 27 | $0 | $522.7K | 2023-06-30 |
| Harrington-Smith Kristen | SVP & Chief Commercial Officer | 4 | $0 | $0 | 2022-11-15 |
| ALTSCHULLER Susan | SVP and CFO | 5 | $0 | $0 | 2022-11-14 |
| Ryll Thomas | VP, Technical Operations | 11 | $0 | $277.4K | 2021-06-30 |
| FOSTER DAVID G | V.P.-Fin., Prin. Acctg. Off. | 15 | $0 | $89.2K | 2020-12-31 |
| BARROWS CRAIG | Vice-President,General Counsel | 29 | $17.1K | $839.3K | 2020-02-24 |
| McKee Blaine H. | EVP & Chief Business Officer | 2 | $0 | $0 | 2019-07-01 |
| Gregory Richard J. | Executive VP & CSO | 12 | $29.5K | $661.3K | 2019-01-31 |
| Johnston David Brannon | Chief Financial Officer | 19 | $17.0K | $614.6K | 2018-06-06 |
| JUNIUS DANIEL M | Director | 86 | $0 | $3.62M | 2018-03-16 |
| VILLAFRANCA JOSEPH J | Director | 29 | $0 | $0 | 2017-12-31 |
| PIEN HOWARD H | Director | 37 | $0 | $0 | 2017-12-31 |
| Williams Peter J. | VP, Business Development | 7 | $0 | $0 | 2017-02-23 |
| LAMBERT JOHN | Executive Vice President | 85 | $4.7K | $2.55M | 2016-11-02 |
| Poole Sandra | Senior VP, Tech Operations | 3 | $0 | $0 | 2016-10-19 |
| Harrison Ellie | VP & Chief HR Officer | 3 | $0 | $0 | 2016-07-18 |
| Morris Charles Q | Executive VP & CDO | 19 | $0 | $774.2K | 2016-07-18 |
| ONETTO NICOLE | Director | 11 | $0 | $44.5K | 2015-11-10 |
| O'Leary James J | Vice President | 21 | $0 | $1.97M | 2014-07-17 |
| PERRY GREGORY D | Chief Financial Officer | 5 | $0 | $326.8K | 2013-09-10 |
| SKALETSKY MARK B | Director | 2 | $0 | $0 | 2012-11-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 960,000 | — | $0 | 0 | SEC↗ |
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,515 | — | $0 | 0 | SEC↗ |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 400,000 | — | $0 | 0 | SEC↗ |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 22,825 | — | $0 | 0 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,519 | — | $0 | 0 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | D To issuer deriv | 2024-02-12 | 2024-02-12 | 51,625 | — | $0 | 0 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | D To issuer deriv | 2024-02-12 | 2024-02-12 | 295,975 | — | $0 | 0 | SEC↗ |
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFIC | D To issuer deriv | 2024-02-12 | 2024-02-12 | 47,375 | — | $0 | 0 | SEC↗ |
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFIC | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,458 | — | $0 | 0 | SEC↗ |
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFIC | D To issuer deriv | 2024-02-12 | 2024-02-12 | 284,250 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 25,556 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,303 | — | $0 | 0 | SEC↗ |
| McCain Tracey L | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 105,458 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 12,666 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 35,871 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 121,905 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 115,273 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 140,400 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 87,500 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 21,364 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 16,666 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 1,333 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 48,000 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 9,267 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer deriv | 2024-02-12 | 2024-02-12 | 48,360 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 4,167 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 63,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 15,800 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 160,350 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 12,625 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,610 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 53,831 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 25,250 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,139 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 6,555 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 8,250 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 39,370 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 258,195 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 28,700 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 65,000 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 39,293 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 303,465 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 150,610 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 102,326 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 925,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 922,400 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 1,100,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 1,100,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 196,875 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 140,357 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer deriv | 2024-02-12 | 2024-02-12 | 102,466 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 32,066 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 40,932 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 74,954 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 5,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 18,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 142,667 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | D To issuer | 2024-02-12 | 2024-02-12 | 1,327 | — | $0 | 0 | SEC↗ |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | D To issuer | 2024-02-12 | 2024-02-12 | 1,000 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | D To issuer | 2024-02-12 | 2024-02-12 | 21,039 | — | $0 | 0 | SEC↗ |
| Arbuckle Stuart A | Director | D To issuer | 2024-02-12 | 2024-02-12 | 5,381 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer | 2024-02-12 | 2024-02-12 | 60,720 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | D To issuer | 2024-02-12 | 2024-02-12 | 14,723 | — | $0 | 0 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | D To issuer | 2024-02-12 | 2024-02-12 | 73,274 | — | $0 | 0 | SEC↗ |
| Wallace Richard John | Director | D To issuer | 2024-02-12 | 2024-02-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | D To issuer | 2024-02-12 | 2024-02-12 | 584,397 | — | $0 | 0 | SEC↗ |
| Thackray Helen M. | Director | D To issuer | 2024-02-12 | 2024-02-12 | 3,074 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | D To issuer | 2024-02-12 | 2024-02-12 | 103,000 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | S Sale | 2024-02-05 | 2024-02-06 | 2,631 | $29.30 | $77.1K | 14,723 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | S Sale | 2024-02-05 | 2024-02-06 | 20,107 | $29.28 | $588.7K | 584,397 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2024-02-05 | 2024-02-06 | 12,027 | $29.30 | $352.4K | 21,039 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2024-02-05 | 2024-02-06 | 4,583 | $29.30 | $134.3K | 73,274 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2024-02-02 | 2024-02-06 | 8,435 | — | $0 | 16,870 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-02-02 | 2024-02-06 | 51,234 | — | $0 | 102,466 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2024-02-02 | 2024-02-06 | 21,840 | — | $0 | 32,760 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2024-02-02 | 2024-02-06 | 7,800 | — | $0 | 15,600 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2024-02-02 | 2024-02-06 | 14,350 | — | $0 | 28,700 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2024-02-02 | 2024-02-06 | 8,435 | — | $0 | 17,354 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-02-02 | 2024-02-06 | 51,234 | — | $0 | 604,504 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2024-02-02 | 2024-02-06 | 29,640 | — | $0 | 33,066 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2024-02-02 | 2024-02-06 | 14,350 | — | $0 | 77,857 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | A Award deriv | 2024-02-01 | 2024-02-05 | 21,364 | — | $0 | 21,364 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-02-01 | 2024-02-05 | 140,357 | — | $0 | 140,357 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | A Award deriv | 2024-02-01 | 2024-02-05 | 10,139 | — | $0 | 10,139 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | A Award deriv | 2024-02-01 | 2024-02-05 | 39,293 | — | $0 | 39,293 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | A Award deriv | 2024-02-01 | 2024-02-05 | 19,519 | — | $0 | 19,519 | SEC↗ |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | A Award deriv | 2024-02-01 | 2024-02-05 | 22,825 | — | $0 | 22,825 | SEC↗ |
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | A Award deriv | 2024-02-01 | 2024-02-05 | 50,515 | — | $0 | 50,515 | SEC↗ |
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFIC | A Award deriv | 2024-02-01 | 2024-02-05 | 19,458 | — | $0 | 19,458 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2024-01-16 | 2024-01-18 | 2,667 | — | $0 | 1,333 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2024-01-16 | 2024-01-18 | 126,100 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2024-01-16 | 2024-01-18 | 58,900 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2024-01-16 | 2024-01-18 | 187,667 | $29.64 | $5.56M | 3,426 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2024-01-16 | 2024-01-18 | 126,100 | $5.25 | $662.0K | 191,093 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2024-01-16 | 2024-01-18 | 2,667 | $5.75 | $15.3K | 64,993 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2024-01-16 | 2024-01-18 | 58,900 | $4.83 | $284.5K | 62,326 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-12-29 | 2024-01-03 | 30,000 | — | $0 | 303,465 | SEC↗ |
| Thackray Helen M. | Director | A Award | 2023-12-29 | 2024-01-03 | 252 | $29.65 | $7.5K | 3,074 | SEC↗ |
| Arbuckle Stuart A | Director | A Award | 2023-12-29 | 2024-01-03 | 442 | $29.65 | $13.1K | 5,381 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2023-12-29 | 2024-01-03 | 569 | $29.65 | $16.9K | 60,720 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | A Award | 2023-12-29 | 2024-01-03 | 467 | $16.01 | $7.5K | 8,919 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | A Award | 2023-12-29 | 2024-01-03 | 615 | $16.01 | $9.8K | 3,426 | SEC↗ |
| VASCONCELLES MICHAEL | EVP R&D & MEDICAL AFFAIRS | A Award | 2023-12-29 | 2024-01-03 | 1,327 | $16.01 | $21.2K | 1,327 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-12-29 | 2024-01-03 | 30,000 | $5.32 | $159.6K | 63,140 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | A Award | 2023-12-29 | 2024-01-03 | 367 | $16.01 | $5.9K | 63,507 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | S Sale | 2023-12-26 | 2023-12-27 | 6,548 | $29.74 | $194.7K | 8,452 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-12-22 | 2023-12-27 | 15,000 | — | $0 | 22,500 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-12-22 | 2023-12-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-12-15 | 2023-12-19 | 27,788 | — | $0 | 35,871 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-12-15 | 2023-12-19 | 89,657 | — | $0 | 115,273 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-12-15 | 2023-12-19 | 117,445 | $29.40 | $3.45M | 2,811 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-12-15 | 2023-12-19 | 89,657 | $5.32 | $477.0K | 120,256 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-12-15 | 2023-12-19 | 27,788 | $4.55 | $126.4K | 30,599 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-11-30 | 2023-12-01 | 30,733 | — | $0 | 9,267 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-11-30 | 2023-12-01 | 133,691 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | M Exercise deriv | 2023-11-30 | 2023-12-05 | 10,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | M Exercise deriv | 2023-11-30 | 2023-12-05 | 10,000 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-11-30 | 2023-12-01 | 30,733 | $10.79 | $331.6K | 167,235 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-11-30 | 2023-12-01 | 133,691 | $10.65 | $1.42M | 136,502 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-11-30 | 2023-12-01 | 164,424 | $28.95 | $4.76M | 2,811 | SEC↗ |
| Peterson Kristine | Director | M Exercise | 2023-11-30 | 2023-12-05 | 10,000 | $10.10 | $101.0K | 10,000 | SEC↗ |
| Peterson Kristine | Director | S Sale | 2023-11-30 | 2023-12-05 | 20,000 | $28.90 | $578.0K | 0 | SEC↗ |
| Peterson Kristine | Director | M Exercise | 2023-11-30 | 2023-12-05 | 10,000 | $13.07 | $130.7K | 20,000 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-11-30 | 2023-12-05 | 3,826 | $29.20 | $111.7K | 33,140 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-11-29 | 2023-12-01 | 6,792 | — | $0 | 133,691 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-11-29 | 2023-12-01 | 6,792 | $16.66 | $113.2K | 2,811 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-11-29 | 2023-12-01 | 6,792 | $10.65 | $72.3K | 9,603 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-17 | 2023-11-17 | 2,200 | — | $0 | 48,823 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-17 | 2023-11-17 | 76,023 | — | $0 | 76,787 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-17 | 2023-11-17 | 2,200 | $4.92 | $10.8K | 39,166 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-17 | 2023-11-17 | 76,023 | $7.69 | $584.6K | 115,189 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-11-17 | 2023-11-17 | 78,223 | $16.05 | $1.26M | 36,966 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-16 | 2023-11-17 | 900 | — | $0 | 152,810 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-16 | 2023-11-17 | 3,200 | — | $0 | 51,023 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-16 | 2023-11-17 | 3,200 | $4.92 | $15.7K | 40,166 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-16 | 2023-11-17 | 900 | $7.69 | $6.9K | 41,066 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-11-16 | 2023-11-17 | 4,100 | $16.01 | $65.6K | 36,966 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-15 | 2023-11-17 | 5,300 | — | $0 | 153,710 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-11-15 | 2023-11-17 | 20,986 | — | $0 | 54,223 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-11-15 | 2023-11-17 | 166,725 | — | $0 | 41,681 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-15 | 2023-11-17 | 20,986 | $4.92 | $103.3K | 57,952 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-11-15 | 2023-11-17 | 5,300 | $7.69 | $40.8K | 63,252 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-11-15 | 2023-11-17 | 26,286 | $16.01 | $420.8K | 36,966 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-11-15 | 2023-11-17 | 166,725 | $15.85 | $2.64M | 2,811 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-11-15 | 2023-11-17 | 166,725 | $4.55 | $758.6K | 169,536 | SEC↗ |
| Wallace Richard John | Director | M Exercise deriv | 2023-11-07 | 2023-11-08 | 10,000 | — | $0 | 0 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-11-07 | 2023-11-08 | 19,517 | — | $0 | 140,483 | SEC↗ |
| Wallace Richard John | Director | M Exercise | 2023-11-07 | 2023-11-08 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-11-07 | 2023-11-08 | 19,517 | $10.65 | $207.9K | 22,328 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-11-07 | 2023-11-08 | 19,517 | $16.66 | $325.2K | 2,811 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 9,000 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 2,619 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 23,000 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 14,373 | — | $0 | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 4,024 | — | $0 | 12,625 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 55,550 | — | $0 | 25,250 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise deriv | 2023-11-06 | 2023-11-08 | 11,962 | — | $0 | 53,831 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 4,024 | $6.98 | $28.1K | 152,033 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 14,373 | $5.25 | $75.5K | 148,009 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 23,000 | $10.65 | $244.9K | 133,636 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 2,619 | $2.68 | $7.0K | 110,636 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 9,000 | $10.79 | $97.1K | 108,017 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | S Sale | 2023-11-06 | 2023-11-08 | 219,545 | $15.29 | $3.36M | 0 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 11,962 | $5.32 | $63.6K | 219,545 | SEC↗ |
| Lentini Renee | VP & PRIN ACCTG OFFICER | M Exercise | 2023-11-06 | 2023-11-08 | 55,550 | $7.69 | $427.2K | 207,583 | SEC↗ |
| Goldberg Mark Alan | Director | M Exercise deriv | 2023-10-30 | 2023-11-01 | 10,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | M Exercise | 2023-10-30 | 2023-11-01 | 10,000 | $14.70 | $147.0K | 70,151 | SEC↗ |
| Goldberg Mark Alan | Director | M Exercise | 2023-10-30 | 2023-11-01 | 10,000 | $15.08 | $150.8K | 60,151 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-10-16 | 2023-10-18 | 33,363 | — | $0 | 208,406 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-10-16 | 2023-10-18 | 158,641 | — | $0 | 63,659 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-10-16 | 2023-10-18 | 33,363 | $4.55 | $151.8K | 194,815 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-10-16 | 2023-10-18 | 192,004 | $14.40 | $2.76M | 2,811 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-10-16 | 2023-10-18 | 158,641 | $4.55 | $721.8K | 161,452 | SEC↗ |
| Goldberg Mark Alan | Director | A Award | 2023-09-29 | 2023-10-02 | 1,063 | $15.87 | $16.9K | 60,151 | SEC↗ |
| Arbuckle Stuart A | Director | A Award | 2023-09-29 | 2023-10-02 | 827 | $15.87 | $13.1K | 4,939 | SEC↗ |
| Thackray Helen M. | Director | A Award | 2023-09-29 | 2023-10-02 | 472 | $15.87 | $7.5K | 2,822 | SEC↗ |
| MITCHELL DEAN J | Director | M Exercise | 2023-09-22 | 2023-12-19 | 10,000 | $14.70 | $147.0K | 103,000 | SEC↗ |
| MITCHELL DEAN J | Director | M Exercise deriv | 2023-09-22 | 2023-09-26 | 10,000 | — | $0 | 0 | SEC↗ |
| MITCHELL DEAN J | Director | M Exercise | 2023-09-22 | 2023-09-26 | 10,000 | $14.70 | $147.0K | 152,667 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | A Award deriv | 2023-09-18 | 2023-09-19 | 51,625 | — | $0 | 51,625 | SEC↗ |
| White Lauren | SVP, CFO AND PFO | A Award deriv | 2023-09-18 | 2023-09-19 | 295,975 | — | $0 | 295,975 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-09-15 | 2023-09-19 | 25,334 | — | $0 | 12,666 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-09-15 | 2023-09-19 | 50,000 | — | $0 | 241,769 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise deriv | 2023-09-15 | 2023-09-19 | 33,334 | — | $0 | 16,666 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-09-15 | 2023-09-19 | 25,334 | $2.68 | $67.9K | 194,824 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-09-15 | 2023-09-19 | 50,000 | $4.55 | $227.5K | 136,156 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | S Sale | 2023-09-15 | 2023-09-19 | 192,013 | $15.44 | $2.96M | 2,811 | SEC↗ |
| Wingrove Theresa | SVP OF REGULATORY AFFAIRS | M Exercise | 2023-09-15 | 2023-09-19 | 33,334 | $3.05 | $101.7K | 169,490 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | M Exercise deriv | 2023-09-13 | 2023-09-14 | 10,000 | — | $0 | 0 | SEC↗ |
| Peterson Kristine | Director | M Exercise deriv | 2023-09-13 | 2023-09-14 | 10,000 | — | $0 | 0 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| MCCLUSKI STEPHEN C | Director | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $16.05 | $160.5K | 0 | SEC↗ |
| Peterson Kristine | Director | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $14.70 | $147.0K | 10,000 | SEC↗ |
| Peterson Kristine | Director | M Exercise | 2023-09-13 | 2023-09-14 | 10,000 | $16.08 | $160.8K | 0 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-09-12 | 2023-09-14 | 3,809 | — | $0 | 14,373 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-09-12 | 2023-09-14 | 9,832 | — | $0 | 6,555 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-09-12 | 2023-09-14 | 11,500 | — | $0 | 0 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-09-12 | 2023-09-14 | 9,832 | $4.55 | $44.7K | 95,208 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-09-12 | 2023-09-14 | 3,809 | $5.25 | $20.0K | 99,017 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-09-12 | 2023-09-14 | 11,500 | $3.05 | $35.1K | 85,376 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-09-08 | 2023-09-11 | 26,006 | — | $0 | 159,010 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-09-08 | 2023-09-11 | 26,006 | $7.69 | $200.0K | 36,966 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-08-09 | 2023-08-11 | 100,210 | — | $0 | 75,209 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-08-09 | 2023-08-11 | 100,210 | $14.20 | $1.42M | 10,960 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-08-09 | 2023-08-11 | 100,210 | $4.92 | $493.0K | 111,170 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-04 | 2023-08-04 | 300,000 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-04 | 2023-08-04 | 782,240 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-04 | 2023-08-04 | 21,978 | — | $0 | 196,875 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-08-04 | 2023-08-04 | 80,326 | — | $0 | 175,419 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-08-04 | 2023-08-04 | 300,000 | $5.65 | $1.70M | 1,545,667 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | S Sale | 2023-08-04 | 2023-08-04 | 992,397 | $16.96 | $16.83M | 553,270 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-08-04 | 2023-08-04 | 21,978 | $4.55 | $100.0K | 1,245,667 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-08-04 | 2023-08-04 | 782,240 | $5.25 | $4.11M | 1,223,689 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise | 2023-08-04 | 2023-08-04 | 80,326 | $4.92 | $395.2K | 91,286 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | S Sale | 2023-08-04 | 2023-08-04 | 80,326 | $17.05 | $1.37M | 10,960 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 16,381 | — | $0 | 2,619 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 6,000 | — | $0 | 0 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-03 | 2023-08-04 | 28,652 | — | $0 | 0 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-03 | 2023-08-04 | 2,760 | — | $0 | 782,240 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-03 | 2023-08-04 | 186,093 | — | $0 | 196,875 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-03 | 2023-08-04 | 831,147 | — | $0 | 218,853 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-03 | 2023-08-04 | 28,652 | $2.31 | $66.2K | 57,495 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-03 | 2023-08-04 | 16,381 | $2.68 | $43.9K | 73,876 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-03 | 2023-08-04 | 6,000 | $2.47 | $14.8K | 28,843 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-08-03 | 2023-08-04 | 2,760 | $5.25 | $14.5K | 444,209 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-08-03 | 2023-08-04 | 1,017,240 | $4.55 | $4.63M | 1,461,449 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | S Sale | 2023-08-03 | 2023-08-04 | 1,020,000 | $16.61 | $16.94M | 441,449 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 29,907 | — | $0 | 65,793 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 18,218 | — | $0 | 18,182 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 40,348 | — | $0 | 28,652 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 23,751 | — | $0 | 16,649 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 36,053 | — | $0 | 16,387 | SEC↗ |
| Enyedy Mark J | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-08-02 | 2023-08-04 | 995,157 | — | $0 | 382,968 | SEC↗ |
| Coen Stacy Ann | SVP & CHIEF BUSINESS OFFICER | M Exercise deriv | 2023-08-02 | 2023-08-04 | 4,255 | — | $0 | 255,745 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-02 | 2023-08-04 | 18,218 | $5.25 | $95.6K | 41,061 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-02 | 2023-08-04 | 40,348 | $2.31 | $93.2K | 81,409 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-02 | 2023-08-04 | 36,053 | $4.55 | $164.0K | 117,462 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-02 | 2023-08-04 | 23,751 | $6.98 | $165.8K | 141,213 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | S Sale | 2023-08-02 | 2023-08-04 | 148,277 | $17.55 | $2.60M | 22,843 | SEC↗ |
| Lentini Renee | PRIN. FIN & ACCTG. OFF. | M Exercise | 2023-08-02 | 2023-08-04 | 29,907 | $5.32 | $159.1K | 171,120 | SEC↗ |